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LipogenesisThe crosstalk between mTORC1/S6K1 signaling and AMPK is emerging as a powerful and highly regulated way
to gauge cellular energy and nutrient content. The aim of the current study was to determine the mechanism by
which exercise training reverses lipid-induced insulin resistance and the role of AMPK/mTOR/S6K1 signaling
axis in mediating this response in skeletal muscle. Our results showed that high-fat feeding resulted in de-
creased glucose tolerance, which was associated with decreased Akt expression and increased intramuscular
triglyceride deposition in the skeletal muscle of C57BL/6 mice. Impairments in lipid metabolismwere accompa-
nied by increased total protein and phosphorylation of S6K1, SREBP-1c cleavage, and decreased AMPK phos-
phorylation. Exercise training reversed these impairments, resulting in improved serum lipid proﬁles and
glucose tolerance. C2C12 myotubes were exposed to palmitate, resulting in an increased insulin-dependent
Akt Ser473 phosphorylation, associated with a signiﬁcant increase in the level of phosphorylation of S6K1 on
T389. All these changes were reversed by activation of AMPK. Consistent with this, inhibition of AMPK by com-
pound C induced an enhanced phosphorylation of both S6K1 and Akt, and silencing of S6K1with siRNA showed
no effect on Akt phosphorylation in both the absence and presence of palmitate cultured myotubes. In addition,
compound C led to an elevated SREBP-1c cleavage but was blocked by S6K1 siRNA. In summary, exercise train-
ing inhibits SREBP-1c cleavage through AMPK/mTOR/S6K1 signaling, resulting in decreased intramyocellular
lipid accumulation. Our results provide new insights into themechanism bywhich AMPK/mTOR/S6K1 signaling
axis mediates the physiological process of exercise-induced insulin sensitization.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Excessive supply of high-fat diet (HFD) and lack of exercise-induced
caloric consumption might be the main factors leading to insulin resis-
tance (IR) associated with type 2 diabetes (T2DM) and obesity. Chronic
consumption of a HFD increases the circulation of non-esteriﬁed fatty
acids (NEFA) resulting in marked skeletal muscle IR characterized by
intramuscular triglyceride deposition and hyperlipidemia in rodents
and humans [1,2]. Various strategies have been proposed to combat
IR, including lifestyle modiﬁcations and pharmacologic interventions
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l rights reserved.potent means to improve insulin action in muscle. We and others
have previously proved that exercise training could reverse the effects
of HFD on skeletal muscle IR [1,2]. However, the precise mechanisms
by which lipids induce IR and exercise training reverses these defects
in skeletal muscle are still elusive.
Mammalian target of rapamycin (mTOR), a serine/threonine kinase,
has been implicated in a number of speciﬁc human pathologies, includ-
ing obesity, T2DM and cancer [5,6]. mTOR signals in at least two distinct
multiprotein complexes, mTOR complex 1 (mTORC1) and mTOR com-
plex 2 (mTORC2), distinguished by their partner proteins and differing
sensitivities to rapamycin [7]. mTORC1 is rapamycin-sensitive and
thought to mediate many of its downstream effects through S6K1 and
initiation factor 4E-binding protein 1 (4E-BP1) [6]. Some evidence has
demonstrated that overactivation of mTORmay be associated with im-
pairments to skeletal muscle insulin action in rodents consuming a HFD
[8]. In contrast, S6K1 null mice are protected from HFD-induced IR [9],
implicating mTORC1 activation as a possible mechanism for impaired
insulin action in response to elevated lipid availability. When nutrients
are available, mTOR is activated and drives anabolism as well as energy
storage and consumption. mTORC1 activation contributes to obesity by
mediating excess fat deposition in white adipose tissue (WAT), liver,
and muscle through the transcription factor sterol regulatory element
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as ceramide and diacylglycerol (DAG) in cells have been implicated as
a detrimental factor to insulin signaling transduction in a variety of
tissues [11]. In cultured cells, chronic mTORC1 hyperactivation has
been shown to contribute to IR through a S6K1-dependent, negative-
feedback mechanism by promoting inhibitory serine phosphorylation
and subsequent degradation of IRS1, leading to an attenuated Akt sig-
naling and insulin desensitization [9].
Apart from insulin and nutrients, cellular energy status is a key
regulator of mTORC1 signaling [12]. It has been suggested that
mTOR may sense cellular ATP levels because it has a high Km (around
1 mM). However, this Km value is still considerably lower than nor-
mal cellular ATP levels; therefore, a drastic decrease in ATP would
be required to affect the activity of mTOR [12]. The AMP-activated
protein kinase (AMPK) has been proposed as a much more sensitive
energy sensor in cells. AMPK, a highly conserved heterotrimeric ki-
nase complex composed of a catalytic (α) subunit and two regulatory
(β and γ) subunits, is activated under conditions of energy stress
when intracellular ATP levels decline and intracellular AMP increases,
as occurs during nutrient deprivation, hypoxia, and physical exercise
[1,13]. Moreover, AMPK also mediates the suppression of expression
of lipogenic genes, including fatty acid synthase (FAS) and acetyl-
CoA carboxylase (ACC), via reduction of SREBP-1c activity [14].
Recent evidence indicates that mTORC1 and AMPK may represent
two antagonistic forces governing muscle adaptation to nutrition,
starvation, and growth stimulation [15]. Activation of AMPK leads to
the inhibition of mTORC1 in a TSC1/2-dependent or ‐independent
mechanism [10,16,17]. Moreover, in animal models with impaired
mTORC1 signaling, AMPK is highly activated [18], suggesting a nega-
tive crosstalk between these two pathways. A study by Rivas et al.
showed that diet-induced mTORC1 over-stimulation and skeletal
muscle IR were reversed by 4 weeks of exercise training, which was
associated with enhanced muscle AMPK activation [13]. All of the
above results raise the intriguing possibility that AMPK-dependent
mTORC1 signaling inhibition in skeletal muscle may be a critical
mechanism in the process of endurance exercise ameliorating IR.
However, direct evidence of the molecular link between AMPK and
mTOR, especially in the insulin-resistant state, and the role and un-
derlying mechanisms of this interaction in the regulating process of
aerobic exercise ameliorating IR still need to be determined.
In the present study, we used a model of lipid-induced IR, the
HFD-fed C57BL/6 mouse, to examine the health promoting effects
of regular exercise training under the condition of an unaltered
high-fat dietary pattern. We observed that 6-week aerobic exercise
training increased whole-body insulin sensitivity. Furthermore, in-
stead of the mTORC1/S6K1-driven inhibitory feedback mechanism
causing attenuation of IRS1/Akt signaling, mTORC1/S6K1-mediated
activated lipogenesis through SREBP-1c activation, resulting in exces-
sive lipid accumulation in skeletal muscle may be one of the crucial
mechanisms contributing to the decreased insulin sensitivity caused
by long-term HFD-feeding. Accordingly, activation of AMPK by aero-
bic exercise may protect the skeletal muscle from increased triglyc-
eride deposition by exerting an inhibitory effect on mTORC1/S6K1
signaling pathway. Together, our results provide new insights into
the molecular connections between AMPK and mTOR/S6K1 signaling
pathway and the mechanism by which AMPK/mTOR/S6K1 signaling
axis mediates the physiological process of exercise-induced insulin
sensitization.
2. Material and methods
2.1. Animals
Thirty 4-week old male wild-type C57BL/6 mice were housed in
vented cages in a temperature-controlled room (20–23 °C; 35–55%
humidity) with a 12-hour light/dark cycle and free access to foodand water. This research was approved by the Tianjin Medical Univer-
sity Animal Care and Use Committee under the guidelines of the
Chinese Academy of Sciences.
At the beginning of the experiment, mice were acclimated to a con-
trol diet for 7 days and were then divided into control (n=10) and
HFD-fed (n=20) groups, and fed with normal diet and HFD (45% cal-
ories from fat, #D12451, Research Diets), respectively, for 10 weeks.
During the subsequent 6-week experimental period, HFD-fed mice
continued to eat a high-fat diet and were randomly allocated to HFD
control group (n=10) and HFD exercise group (n=10). The mice
from the exercise group were exercised on a motor-driven rodent
treadmill for 5 days a week for a total of 6 weeks. The mice initially
ran at the intensity of 50% VO2 max for 20 min/day during the ﬁrst
week; thereafter, the running intensity and time were increased to
75% VO2 max (12 m/min) for 60 min/day [19].
2.2. Oral glucose tolerance test (OGTT), fasting serum insulin (FIN), and
metabolic proﬁles
After the desired length of exercise training (6 weeks), animals
were food-restricted for at least 12 h overnight. Blood samples were
taken for fasting serum insulin and lipid assay and an OGTT was ad-
ministered. Blood was collected from a cut at the end of the tail im-
mediately before and at 15, 30, 60, 90, and 180 min after glucose
administration. Mice were then killed, and a portion of quadriceps
was isolated.
2.3. Cell culture and treatments
C2C12 cells were cultured in Dulbecco's modiﬁed Eagle's medium
(DMEM) supplemented with 10% FBS and maintained at 37 °C in a
humidiﬁed atmosphere with 5% CO2 as previously described [20].
Cells were seeded in a six-well plate and differentiated in DMEM
with 2% horse serum for 6 days. siRNA transfection was performed
with Lipofectamine™ according to the manufacturer's instructions
(Invitrogen, Carlsbad, CA). For palmitate treatment, cells were incubat-
ed with 0.8 mMpalmitate in ethanol vehicle for 15 h in DMEMwith 1%
fatty acid-free BSA. For insulin-stimulated conditions, 200 nM insulin
was added to appropriate wells during the last 30 min of incubations.
All experiments were run in triplicate.
2.4. Oil red O (ORO) staining and immunoﬂuorescence assay
Tissues were cut into small cubes and embedded in optimal cutting
temperature (OCT) freezing media and cryosectioned at 8 μm. ORO
staining was performed in accordance to Koopman et al. [21]. The fro-
zen sections were immunostained with the primary anti-FAT/CD36 an-
tibody (a gift from Dr. Lei Cai, University of Kentucky). First, the section
was blockedwith blocking buffer (0.2% TritonX-100, 1% BSA, 1% normal
goat serumdilution in PBS) for 1 h to avoid unspeciﬁc binding and incu-
bated overnight at 4 °C with primary antibody. After being washed
three times with PBS, a mixture of Alexa Fluor® 488-conjugated sec-
ondary antibody was added for 1 h at room temperature, followed by
incubation in Hoechst for 5 min. The images were captured by ﬂuores-
cence microscope.
2.5. Immunoprecipitation
Anti-CPT1 primary antibody was cross-linked to Dynabeads®
Protein A (Invitrogen, Carlsbad, CA) according to the manufacturer's
protocol. Tissue lysates were precleared with IgG Dynabeads® Pro-
tein A for 10 min and then incubated with CPT1-Dynabeads overnight
at 4 °C. CPT1 immunoprecipitated complexes were washed ﬁve times
with washing buffer. Proteins were eluted by boiling in loading buffer
and then processed for western blot analysis.
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PCR Total RNA from quadriceps femoris of each sample was
subjected to reverse transcription using SuperScript™ First-Strand
Synthesis System for RT-PCR (Invitrogen, Carlsbad, CA) for cDNA syn-
thesis. Synthesized cDNA was used for PCR with speciﬁc primers
(Table 1) at optimized cycles. Real-time PCR was performed using
Bio-Rad iQ5 Real-Time PCR system (Bio-Rad Laboratories, Hercules,
CA) and FastStart Universal SYBR Green Master (Rox) (Roche Applied
Science, Indianapolis, IN), according to the manufacturer's instruc-
tions. We quantiﬁed transcripts of the housekeeping gene glyceralde-
hydes 3-phosphate dehydrogenase (GAPDH) as control. Relative
expression level of target gene was determined as 2-ΔΔCT.2.7. Western blot analysis
Protein extracts from tissues/cells were made in freshly prepared
NP-40 lysis buffer. Equal amounts of protein were separated by
SDS-PAGE, and transferred to PVDF membranes (Millipore, Bedford,
MA). The membranes were blocked and incubated overnight at 4 °C
with antibodies speciﬁc for Akt, phospho-Akt Ser473/Thr308, ACC,
phospho-ACC S79, AMPK, phospho-AMPK T172, IRS1 S636/639 (Cell
Signaling Technology, MA), CPT-1 (LifeSpan Biosciences, WA), S6K1,
phospho-S6K1 Thr389, or SREBP-1c (Abcam, MA). The immunoreac-
tive proteins were detected with chemiluminescent horseradish per-
oxidase (HRP) substrate (Millipore, Bedford, MA) and quantiﬁed by
densitometry. All results are representative of three independent
experiments.2.8. Statistical analysis
All data are expressed as means±SEM. Signiﬁcant differences were
assessed by two-tailed Student's t test or one-way ANOVA followed by
the Student–Newman–Keuls test. Pb0.05 was considered statistically
signiﬁcant.3. Results
3.1. Effects of HFD and exercise training on body weight, metabolic
proﬁles, and glucose tolerance
As shown previously [2], the body mass of C57BL/6 mice was in-
creased by high-fat feeding and was reversed by aerobic exercise
training (Pb0.05; Fig. 1A). Serum total cholesterol concentration
was elevated in the HFD group by 77.02% (Pb0.05 vs. normal diet)
but decreased in the high-fat exercise training group (Pb0.05 vs.
HFD; Fig. 1B). Serum triglyceride concentration was also decreased
in mice in the high-fat exercise training group (Pb0.01 vs. HFD;
Fig. 1C). HFD mice had higher fasting insulin levels (Pb0.01 vs. nor-
mal diet), whereas 6-week exercise training caused a signiﬁcant de-
crease in the high-fat exercise training group (Pb0.05 vs. HFD;
Fig. 1D). We further examined glucose tolerance and clearance by
OGTTs. Consistent with these changes, the curve for glucose levels
during OGTT showed that glucose intolerance induced by HFD was
also reversed by 6 weeks of aerobic exercise (Fig. 1E).Table 1
Primer sequences for real-time RT-PCR.




All primer sequences are shown 5′ to 3′, left to right.3.2. Effects of HFD and exercise training on lipid metabolism in skeletal
muscle of C57BL/6 mice
To further elucidate the effects of HFD and exercise training on
lipid metabolism, intracellular lipid accumulation in skeletal muscle
was examined. As shown in Fig. 2A, 6 weeks of aerobic exercise train-
ing eliminated excess fat accumulation in skeletal muscle that was in-
duced by long-term HFD-feeding, as determined by ORO staining
(Fig. 2A).
CPT-1 plays a major role in the regulation of β-oxidation because
it functions as a rate-limiting step in long-chain fatty acids (LCFA)
transport into the mitochondria [22]. CPT-1 protein expression in
skeletal muscle was not changed in HFD-fed mice compared with
that of mice maintained on the normal diet, but was increased by
~14% with the combination of HFD and exercise training (Fig. 2C);
these results are similar to those in our previous report [23]. These
changes in CPT-1 protein expression were accompanied by similar al-
ternations in mRNA levels among groups (Fig. 2B). In contrast, fatty
acid translocase (FAT)/CD36, which was also identiﬁed on plasma
membrane and mitochondria in skeletal muscle and found to be in-
volved in LCFA transport and oxidation [24], was increased in re-
sponse to high-fat feeding, as reﬂected by higher levels of mRNA
and protein content in skeletal muscle compared with that of mice
from control group (Fig. 2B and C). Moreover, exercise training large-
ly abolished the HFD-induced increase in FAT/CD36 expression
(Fig. 2B and C). Immunoﬂuorescence assay was carried out to further
detect the subcellular localization of FAT/CD36. The results showed
that HFD feeding promoted the localization of FAT/CD36 on cell mem-
brane. However, this effect of HFD was retarded by exercise training
(Fig. 2D).
Study shows that the amount of FAT/CD36 that coimmuno-
precipitated with CPT1 on mitochondrial membrane was strongly
correlated with whole body fat oxidation [24]. Therefore, immuno-
precipitation techniques were used to determine whether the associ-
ation between FAT/CD36 and CPT1 is altered after HFD feeding and
exercise training intervention. FAT/CD36 was found to coimmuno-
precipitate with CPT1, and the amount of FAT/CD36 that coimmuno-
precipitated with CPT1 decreased by 58% after 16-week HFD feeding
but was increased after exercise training (Fig. 2E).
SREBP-1c is a key lipogenic transcription factor that is regulated
by nutrients and insulin [25]. Activated nuclear form of SREBP-1c is
translocated into the nucleus and regulates the lipogenic process by
activating genes involved in fatty acid and triglyceride synthesis.
Herein, we observed elevated protein concentrations of processed
SREBP-1c in skeletal muscle of HFD-fed mice, but this trend was total-
ly reversed by exercise training, resulting in a signiﬁcantly decreased
expression of SREBP-1c in exercise training group (Fig. 2C).
3.3. Activity of Akt and AMPK/mTOR/S6K1 signaling axis in skeletal
muscle of HFD-fed C57BL/6 mice with or without training intervention
Increased glucose tolerance in mice that underwent exercise
training suggests an increase in insulin sensitivity in peripheral tis-
sues. To test the effects of HFD and aerobic training on insulin signal-
ing transduction, we examined the expression of one key component,
protein kinase B (Akt), in insulin signaling pathways [26] in skeletal
muscle. As reported previously [1], expression of Akt protein was de-
creased in tissues in HFD-fed mice compared with mice maintained
on a control diet, but was increased by 6 weeks of exercise training
(Fig. 3A).
Exercise training completely abolished the HFD-induced increase
in S6K1 mRNA expression such that values were restored to those
observed in the normal diet group (Fig. 3B). Similar to the effect of HFD
on S6K1 mRNA expression, HFD-feeding signiﬁcantly increased the
S6K1 protein content in skeletalmuscle, and this trendwas also reversed
by aerobic exercise training (Fig. 3C). Furthermore, phosphorylation of
Fig. 1. Exercise training decreased body weight, improved plasma lipid proﬁles, hyperinsulinemia, and glucose tolerance. (A) High-fat diet (HFD)-fed mice displayed increased body
weight but was reversed by exercise training (Ex). After 16 weeks of intervention, serum total cholesterol (B), serum triglyceride (C), and serum insulin levels (D) were measured,
followed by fasting overnight. HFD-fed mice displayed hyperinsulinemia but were improved by 6-week exercise training. Results are means±SEM (n=10). *Pb0.05 vs. normal
diet; **Pb0.01 vs. normal diet; #Pb0.05 vs. HFD; ##Pb0.01 vs. HFD. Oral glucose tolerance test (E) was performed in 16-hour-fasted mice (n=10). Mice were given D-glucose
(2 g/kg body wt.) by gavage through a gastric tube (outer diameter 1.2 mm) inserted in the stomach. Blood glucose levels were measured at the time points indicated. Values
are means±SEM.
1719X. Liu et al. / Biochimica et Biophysica Acta 1822 (2012) 1716–1726S6K1on Thr389, a surrogatemeasure ofmTORC1kinase activity,was also
altered by HFD-feeding, with a ~30% increase in skeletal muscle of mice
with high-fat feeding but was normalized by exercise training (Fig. 3C).
Because of its role in suppressing energy consuming processes,
AMPK is known as the physiological inhibitor of mTOR/S6K1 signaling
[16,17,27]. In our study, no changes were noted in the total protein
concentration of the AMPKα. In contrast, phosphorylation of AMPK
on Thr172, a marker of AMPK activity, was decreased in skeletal mus-
cle of C57BL/6 mice by high-fat feeding. However, this diet-induced
effect was reversed by exercise training (Fig. 3C).
3.4. Role of mTORC1/S6K1 signaling in regulation of IRS1/Akt cascade
by palmitate
It has been previously demonstrated that high levels of circulating
NEFA cause toxic effects and contribute to the development of meta-
bolic disorders [1,2,28]. Therefore, we determined whether 0.8 mM
palmitate incubation could activate mTORC1/S6K1 signaling in C2C12
cell line. Although no changes in the total protein level of S6K1 were
observed, there was a signiﬁcant increase in the level of phosphoryla-
tion of S6K1 on T389 with 18 h palmitate treatment (Fig. 4A), demon-
strating that in response to the insulin, mTORC1/S6K1 signaling was
stimulated by increased lipid availability.
Phosphorylation of total Akt on its Ser473 activation site was also
altered by palmitate, with a ~33% increase in palmitate-treated C2C12
cells in response to insulin compared to the control cells (Fig. 4A). There
was virtually no signal in control cells in the basal state (Fig. 4A). How-
ever,we found that culture of C2C12 cellswith palmitate showed anun-
expected increase of insulin-stimulated phosphorylation of IRS1 atS636/639 (Fig. 4A), indicating signiﬁcantly decreased IRS1 activity
caused by palmitate treatment.
To determine the role of the mTOR/S6K1 signaling pathway in Akt
activation in response to palmitate, C2C12 myotubes were treated
with S6K1 RNAi oligos. S6K1 RNAi signiﬁcantly decreased endoge-
nous S6K1 and pS6K1 protein levels (Fig. 4B). Consistent with previ-
ous studies [9], knockdown of S6K1 increased the insulin-dependent
Ser473 phosphorylation of Akt and signiﬁcantly decreased IRS1 phos-
phorylation at S636/639 (Fig. 4B), revealing the existence of a nega-
tive feedback mechanism in regulating insulin signaling activity at
the level of IRS1 by mTOR/S6K1. In contrast, increases in phosphory-
lation of Akt following palmitate treatment resulted in concomitant
increase in mTORC1 activity, as demonstrated by phosphorylation
of its downstream substrate S6K1. Furthermore, knockdown of S6K1
by RNAi induced no further activation of Akt in C2C12 cells incubated
with palmitate, even though phosphorylation of IRS1 at S636/639
showed a drastic reduction under both the absence and presence of
palmitate conditions (Fig. 4B). Taken together, these results suggest
that lipid-induced Akt phosphorylation is independent of mTORC1/
S6K1 signaling pathway and IRS1.
3.5. Role of mTORC1/S6K1 signaling in the regulation of IRS1/Akt cascade
by AMPK
It has been demonstrated that AMPK plays an important role in
the regulation of fatty acid oxidation [29]. In this study, we examined
the effects of prolonged exposure to palmitate on AMPK activity in
C2C12 cells. Similar to the results of chronic lipid oversupply in vivo
experiments, 18 h palmitate treatment decreased the phosphorylation
Fig. 2. Effects of high-fat diet (HFD) and exercise training (Ex) on lipid metabolism in skeletal muscle of C57BL/6 mice. (A) Representative oil red O (ORO) staining of muscle sec-
tions. Exercise training decreased lipid accumulation in skeletal muscle. (B–C) Relative levels of CPT-1 and FAT/CD36 mRNA and protein, active form of SREBP-1c protein (~70 kDa),
were quantiﬁed using real-time RT-PCR and western blot analysis. Results are means±SEM (n=6). *Pb0.05 versus normal diet; #Pb0.05 versus HFD. The subcellular localization of
FAT/CD36 (D) was measured using immunoﬂuorescence assay. Representative confocal immunoﬂuorescence images show FAT/CD36 staining (green) and nuclear staining with
Hoechst (red). Scale bars=20 μm. (E) Reciprocal immunoprecipitation of endogenous FAT/CD36 and CPT1. Tissue lysates were subject to immunoprecipitation with anti-CPT1
antibody. The immunoprecipitates were then blotted with FAT/CD36 antibody. IP and IB denote immunoprecipitation and immunoblot, respectively.
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expression in C2C12 cells in response to palmitate (Fig. 5A).
To test the functional signiﬁcance of AMPK phosphorylation on
mTORC1/S6K1 signaling, C2C12 cells were treated with 5-aminoimida-
zole-4-carboxamide riboside (AICAR), a speciﬁc AMPK activator, and
the regulatory phosphorylation of S6K1 was measured using immu-
noblot analyses. Strikingly, in AMPK-activated cells, palmitate was in-
capable of activating the mTORC1 pathway as detected by the
phosphorylation of S6K1 at T389 (Fig. 5A).
We further examined the function of AMPK in Akt regulation.
Activation of AMPK by AICAR resulted in a decrease of insulin-
stimulated Akt phosphorylation (Fig. 5A). Our observation is consistent
with recent reports that AMPK activation closely correlates with the
inhibition on the activating Ser/Thr phosphorylation of Akt [30,31].
Because inappropriate activation of the mTOR/S6K1 pathway im-
poses a negative feedback program to attenuate IRS/Akt signaling,
we applied (6-[4-(2-piperidin-1-yl-ethoxy)-phenyl)]3‐pyridin-4-yl-
pyrazolo-[1,5-a] pyrimidine, which is also known as compound C
[32], a speciﬁc AMPK inhibitor, to the cells to determine whether
mTOR/S6K functions in Akt regulation by AMPK. Inhibition of AMPK
activity by compound C, as reﬂected by decreased AMPK phosphoryla-
tion, induced a signiﬁcantly enhanced phosphorylation of S6K1 and
insulin-stimulated Akt S473 phosphorylation by ~1.6 and 3.3-fold, re-
spectively (Fig. 5B). Furthermore, if S6K1 mediates the inhibitoryeffects of AMPK on Akt, downregulation of S6K1 activity should
cause an elevated activity of Akt in response to compound C. In con-
trast, in our experiments, knockdown of S6K1 induced Akt phosphor-
ylation in control cells, but not in compound C-treated cells with or
without palmitate (Fig. 5B and C). These results suggest that
mTORC1/S6K1 signaling is not involved in the process of Akt activity reg-
ulation by AMPK in both the absence and presence of palmitate-cultured
cells.
3.6. S6K1 is responsible for the inhibition of SREBP-1c by AMPK in C2C12
myotubes
Consistent with our in vivo results, levels of SREBP-1c cleavage
were also increased under lipid oversupply conditions in C2C12 cells
(Fig. 6A), indicating that expression of the processed SREBP-1c is nutri-
tionally responsive. As AMPK has recently been found to block the pro-
cessing of SREBP isoforms [33], we next examined the effect of AMPK
activation on SREBP-1c expression in C2C12 myotubes. As predicted,
SREBP-1c cleavage was signiﬁcantly decreased by AICAR treatment,
indicating a reverse correlation between palmitate-induced SREBP-1c
cleavage and AMPK activity (Fig. 6A). A signiﬁcant body of evidence
suggests that, in addition to reducing insulin signaling by promoting
IRS-1 phosphorylation or degradation, mTORC1 hyperactivation by
overfeeding may promote de novo lipogenesis by inducing SREBP-1c
Fig. 3. Activity of Akt and AMPK/mTOR/S6K1 signaling axis in skeletal muscle of high-fat diet (HFD)-fed mice with or without training intervention. Western blot analysis of the
expression levels of total Akt (A), S6K1, phospho-S6K1 on T389, AMPK, and phospho-AMPK on T172 (C) in skeletal muscle from HFD-fed or HFD-feeding combined exercise training
(Ex) mice. Tubulin was used as the internal housekeeping protein control. Relative level of S6K1 mRNA expression (B) was quantiﬁed using real-time RT-PCR analysis. Results are
means±SEM (n=6) and *Pb0.05 vs. normal diet; **Pb0.01 vs. normal diet; #Pb0.05 vs. HFD; ##Pb0.01 vs. HFD.
Fig. 4. Lipid-induced Akt phosphorylation is independent of mTORC1/S6K1 signaling pathway and IRS1. (A) Expression levels of S6K1, phosphor-S6K1 on T389, phosphor-Akt on
S473, and phosphor-IRS1 on S636/639 in lysates of C2C12 cells. C2C12 myotubes were incubated in medium with or without 0.8 mM palmitate for 18 h, followed with or without
200 nM insulin stimulation for 30 min. *Pb0.05 vs. Ins (Insulin). (B) Knockdown of S6K1 by RNA interference induced no further activation of Akt in C2C12 cells incubated with
palmitate. C2C12 myotubes were transfected with S6K1 siRNA or negative control as indicated. Cells were incubated with or without 0.8 mM palmitate for 18 h followed by
200 nM insulin stimulation for 30 min. Tubulin was used as the internal housekeeping protein control. Data are means±SEM of at least three independent experiments.
*Pb0.05 vs. Ins; #Pb0.05 vs. Ins+Pal.
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Fig. 5. mTORC1/S6K1 signaling was not involved in the process of Akt activity regulation by AMPK. (A) Activation of AMPK by AICAR decreased insulin-stimulated Akt phosphor-
ylation. C2C12 myotubes were incubated in medium with or without 0.8 mM palmitate and 2 mM AICAR for 18 h, followed with 200 nM insulin (Ins) stimulation for 30 min.
*Pb0.05 vs. Ins+Pal. (B and C) mTORC1/S6K1 signaling was not involved in the process of Akt activity regulation by AMPK in both the absence (B) and presence (C) of
palmitate-cultured cells. C2C12 myotubes were transfected with S6K1 siRNA or negative control as indicated. Then cells were cultured in media with indicated concentration of
palmitate for 18 h in the presence or absence of compound C (60 μM), followed with 200 nM insulin stimulation for 30 min. Phosphorylation of proteins was determined by west-
ern blot using speciﬁc phosphospeciﬁc antibodies as indicated on the left of each strip. Results are means±SEM and *Pb0.05 vs. Ins; #Pb0.05 vs. Ins+RNAi.
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experiments, knockdownof S6K1 as demonstrated by decreased protein
levels of S6K1 and pS6K1 at T389 induced signiﬁcantly decreased levels
of processed active form of SREBP-1c protein in C2C12 cells (Fig. 6B).
Then the effect of AMPK on SREBP-1c cleavage and the role of
mTOR/S6K1 signaling in these processes were determined in C2C12
myotubes under high palmitate plus insulin conditions. Inhibition of
AMPK by compound C led to an elevated SREBP-1c expression by
over 3-fold (Fig. 6C). This effect was blocked by siRNA targeting
S6K1 (Fig. 6C). These ﬁndings indicate that AMPK is sufﬁcient to sup-
press an SREBP-1c-dependent increase in de novo lipogenesis, at least
in part, through the downregulation of mTOR/S6K1 signaling.
We also found that, as illustrated in Fig. 6D, activation of AMPK
by AICAR led to an increased expression of CPT-1 in palmitate plus in-
sulin treated C2C12 myotubes, while silencing of S6K1 with siRNA
showed no effect on CPT-1 expression (Fig. 6D). To test the effect of
mTOR/S6K1 signaling on lipogenic genes, we investigated the effects
of silencing of S6K1 and activation of AMPK on ACC expression. As
shown in Fig. 6D, expression of ACC protein was down-regulated inresponse to S6K1 RNAi treatment, indicating a positive correlation be-
tween mTOR/S6K1 signaling and ACC expression. Both S6K1 inhibi-
tion and AMPK activation increased ACC phosphorylation on serine
79, which inhibits its activity (Fig. 6D).
4. Discussion
Exercise training is known to activate a number of transcriptional
regulators and kinases in skeletal muscles that contribute to meta-
bolic reprogramming, among which AMPK has profound effects on
skeletal muscle gene expression and oxidative metabolism [35,36].
Narkar et al. have validated the belief that orally active AMPK agonist
AICAR is sufﬁcient as a single agent to improve running endurance in
nonexercised mice [37]. Indeed, since AMPK is traditionally described
as a central integrator of signal that controls energy balance, this
should come as no surprise. In vivo studies have also proved that ac-
tivation of AMPK was associated with increased skeletal muscle insu-
lin sensitivity and prevention of obesity-related complications [38].
AMPK plays key roles in glucose and lipid metabolism by promoting
Fig. 6. S6K1 is responsible for the inhibition of SREBP-1c by AMPK. (A) AICAR decreased SREBP-1 cleavage in C2C12 myotubes. Experiments were similar to Fig. 5A. Levels of
processed active form of SREBP-1c protein were determined. (B) Knockdown of S6K1 by siRNA inhibits SREBP-1c cleavage. C2C12 myotubes were transfected with S6K1 siRNA
or negative control, followed with 200 nM insulin stimulation for 30 min. (C) Activation of SREBP-1c cleavage by AMPK inhibition is blocked by S6K1 RNAi. C2C12 myotubes
were transfected with S6K1 siRNA or negative control. Then cells were incubated in 0.8 mM palmitate with or without 2 mM AICAR and 60 μM compound C for 18 h, followed
with 200 nM insulin stimulation for 30 min. (D) Expression levels of CPT-1, ACC, and phosphor-ACC on S79 in lysates of C2C12 cells. C2C12 myotubes were transfected with
S6K1 siRNA or negative control. Then cells were incubated in 0.8 mM palmitate (Pal) with or without 2 mM AICAR for 18 h, followed with 200 nM insulin (Ins) stimulation for
30 min. Results are means±SEM and *Pb0.05 vs. Ins+Pal; #Pb0.05 vs. Ins+Pal+RNAi.
1723X. Liu et al. / Biochimica et Biophysica Acta 1822 (2012) 1716–1726mitochondrial biogenesis and fatty acid oxidation [37,39]. This link is
likely to hold true in vivo, because regular aerobic exercise indeed re-
sults in elevated AMPK activity (Fig. 3C), as demonstrated by in-
creased AMPK T172 phosphorylation, associated with increased
glucose tolerance as determined by OGTT (Fig. 1E) and eliminated ex-
cess fat accumulation in skeletal muscle as determined by ORO
staining (Fig. 2A).
Recent ﬁndings suggest that AMPK's metabolic effects might be
mediated, at least in part, through modulation of mTORC1 activity.
Over the past decade, mTOR kinase has emerged as an essential factor
for cell metabolism, growth, and proliferation [5,6]. Feedback inhibi-
tion of the IRS1/Akt pathway by mTORC1/S6K1 has emerged as an
important signaling event in insulin resistance [9]. However, it is be-
coming increasingly clear that mTOR also controls cell metabolism by
promoting the activation of other anabolic processes, leading to the
synthesis of many classes of lipids [34]. Given the potential for
mTORC1 to both negatively regulate insulin action and positively reg-
ulate lipid biosynthesis, it is plausible to hypothesize that mTORC1/S6K1 signaling may be involved in the differential regulation of
high-fat feeding and exercise training on insulin sensitivity in skeletal
muscle. We demonstrated in vivo that mTORC1/S6K1 activity was
up-regulated by chronic lipid oversupply and that these changes
were completely reversed by exercise training (Fig. 3B and C). Results
of the present investigation are also consistent with those of Rivas et
al., who demonstrated that HFD-stimulated S6K1 activation was de-
creased following endurance training [13].
The hyperactivation of mTORC1 by nutrient excess has been impli-
cated in decreased insulin signal transduction [9]. Recent in vitro
works in skeletal muscle cell culture have directly implicated palmi-
tate with the inhibition of insulin-stimulated glucose uptake through
the activation of mTORC1 and its inhibition of insulin signaling [40].
Contrary to these reports, in the present study we observed an unex-
pected increase in palmitate-induced phosphorylation of S473 on Akt
despite elevated S6K1 activity in C2C12 cells (Fig. 4A), which led to a
concomitant increase in the serine phosphorylation of IRS1 (Fig. 4A).
Discrepancies between Akt activation and upstream insulin signaling
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that mTORC1/S6K1/IRS1-independent pathways also might contribute
to insulin-stimulated Akt activation in response to palmitate. More in-
terestingly, our data that increased Akt activity with palmitate treat-
ment seems a paradoxical ﬁnding given the ability of the fatty acids to
inhibit insulin action. We are not the ﬁrst, however, to report an in-
creased Akt activity in response to elevated fatty acid availability [13].
It is important to consider the fact that deleterious effects in skeletal
muscle are frequently reported after prolonged exposure to elevated
levels of fatty acids [43]. This increase in Akt activity induced by LCFA
could serve as an acute protective mechanism against the potential
toxic effects of elevated circulating concentrations of fatty acids. How-
ever, it still remains to be determined whether a sustained increase
could be observed under conditions where prolonged exposure to
lipid occurs. In our in vivo experiment, expression of Akt protein was
decreased in skeletal muscle of HFD-feeding mice compared with
mice maintained on a control diet, but was normalized by 6 weeks of
exercise training (Fig. 3A). It is possible that the longer duration of
high-fat feeding (10 weeks) used in the present study provided sufﬁ-
cient time to allow for the appearance of insulin resistance.
AMPK is a well-known physiological inhibitor of the energy-
consuming mTOR signaling pathway [15–17]. Accordingly, AMPK acti-
vation in this study may be one possible mechanism to explain the in-
hibition of mTOR/S6K1 activity in response to exercise training. Indeed,
when treating palmitate-incubated C2C12 myotubes with AMPK acti-
vator AICAR, we observed a signiﬁcantly decreased mTORC1 activity
(Fig. 5A). Furthermore, our results proved that activation of AMPK ex-
erts an inhibitory effect on Akt and that this occurs independent of
mTOR/S6K1 signaling (Fig. 5B and C). A previous report also found
Akt to be dephosphorylated following AICAR treatment in C6 glioma
cells [30], further verifying our conclusion. AMPK and Akt generally
have opposing roles in cellular metabolism. AMPK is activated when
AMP levels increase in conjunction with decreased ATP levels, and ac-
tivated AMPK switches off ATP-consuming processes, such as glycogen,
fatty acid, and protein synthesis pathways, and activates alternative
pathways for ATP regeneration. Akt, on the other hand, generally pro-
motes anabolic cellular functions that utilize ATP. Therefore, suppress-
ing the activity of energy-consuming signaling pathways by AMPK to
avoid the insurgence of conﬂicting metabolic signals act as a protective
mechanism for survival of the energy-deprived cells.
In previous studies, exercise training resulted in increased [44],
unchanged [45,46], or decreased [1] insulin-stimulated Akt Ser473
phosphorylation, indicating that Akt activation may not be necessary
for exercise-induced insulin sensitization. As mentioned above, in ad-
dition to the S6K1-dependent negative-feedback mechanism in regu-
lating insulin signaling activity, many lines of evidence suggest that
mTORC1 also mediates the effect of AMPK on de novo lipogenesis
[34]. As expected, we ﬁnd that SREBP-1c, the gene involved in the reg-
ulation of fatty acid storage, is upregulated in palmitate-treated C2C12
myotubes, indicating an elevated lipogenesis in response to increased
lipid availability. However, treating palmitate-incubated cells with
AICAR reversed this effect (Fig. 6A). We prove that AMPK suppresses
SREBP-1c, as well as its target enzyme ACC‐dependent increase in de
novo lipogenesis through the downregulation of mTOR/S6K1 signaling
in C2C12myotubes (Fig. 6C and D). Our results are in agreement with a
recent study that has demonstrated that inhibition of mTORC1 with
rapamycin blocks Akt-induced SREBP-1c nuclear localization and the
expression of lipogenic genes [47]. Despite advances, the exact mecha-
nism by which mTORC1 promotes SREBP-1c cleavage and nuclear
localization in skeletal muscle remains to be determined.
Analogous to the effects of palmitate treatment on SREBP-1c
expression in vitro, we demonstrated that SREBP-1c cleavage was in-
creased in response to HFD-feeding in skeletal muscle but reversed by
exercise training (Fig. 2C). Nutritional regulation of SREBP-1c expres-
sion is well described in liver [32] and adipose tissue [48]. The current
study extends these observations to demonstrate that there is asigniﬁcant stimulation of skeletal muscle SREBP-1c gene expression
with HFD-feeding. The result that exercise-induced reduction in skel-
etal muscle SREBP-1c expression is in accordance with the study of
Boonsong et al., who demonstrated that although SREBP-1c mRNA
content was not affected by exercise, its protein level was lower in
the exercised group than the control leg [49]. Several studies have
also shown that muscle SREBP-1c exhibits responsiveness to acute
exercise and training [50,51]. These observations of decreased muscle
SREBP-1c expression and lipid storage in skeletal muscle (Fig. 2A) pro-
vide a potential mechanism for AMPK-dependent exercise training-
induced insulin sensitization.
Prolonged exposure to elevated levels of lipid leads to impairment
of the cellular capacity to oxidize LCFA and causes an increase in
intracellular lipid accumulation, which could ultimately lead to
lipotoxic effects in this tissue. Therefore, the effects of HFD and exer-
cise training on components of the oxidative metabolism of fatty
acids were further analyzed by measurement of the gene expression
levels of selective biomarkers for fatty acid metabolism. As expected,
we found that CPT1, the gene involved in fatty acid uptake, was
upregulated by exercise training (Fig. 2C), indicating an elevated
fatty acid transport into mitochondria. FAT/CD36 has been isolated
in adipocytes [52] and on plasma membranes [53] and has been
shown to inﬂuence the transport of LCFA across plasma membrane
in skeletal tissue. In the present study, expression and translocation
of FAT/CD36 to plasma membrane were both elevated in response
to HFD feeding but were reversed by exercise training (Fig. 2C and
D). In contrast, we found that the amount of FAT/CD36 that co-
immunoprecipitated with CPT1 increased after endurance exercise
training under the condition of high-fat feeding (Fig. 2E). It has
been demonstrated that FAT/CD36 is present on mitochondrial mem-
branes of rat and human skeletal muscle, and that the amount of FAT/
CD36 that coimmunoprecipitated with CPT1 on mitochondrial mem-
brane was strongly correlated with whole body fat oxidation [24].
Taken together, the increase in fatty acid oxidation after endurance
exercise training might also be the mechanism responsible for im-
provements in insulin sensitivity and overall metabolic health.
In vitro study, we found that activation of AMPK induced an in-
creased expression of CPT-1 protein and decreased ACC activity in pal-
mitate pre-treated C2C12 myotubes (Fig. 6D), suggesting the
beneﬁcial lipidmetabolic effects of AMPK in increasing fatty acid oxida-
tion and decreasing lipogenesis. The mTOR/S6K1 signaling has been
proved to be involved in regulating the process of lipogenesis through
SREBP-1c. The AMPK-mTORC1 gauge adjusts muscle plasticity to envi-
ronmental signals by altering the glycolytic-oxidative properties of the
muscle [54]. The serine phosphorylation of IRS1 protein has been pro-
posed to explain S6K1 effects on insulin sensitivity, although direct ev-
idence is lacking. In the present study, we demonstrate that changes in
the mTORC1/S6K1-mediated lipid metabolism may be one mechanism
to explain the altered insulin sensitivity in response to HFD and aerobic
exercise training. Furthermore, the impairments in the regulation of
fuel metabolism caused by HFD could be referred to as “metabolic in-
ﬂexibility”, which is deﬁned as the impaired capacity to switch between
fat and glucose as the primary fuel source [55]. Further verifying our hy-
pothesis, chronic exercise training improves the capacity of skeletal
muscle to utilize fatty acids for fuel during exercise, indicating an im-
proved metabolic ﬂexibility, thereby reducing lipid intermediates and
improving insulin sensitivity [55]. In conclusion, our results suggest
that the control of mTORC1/S6K1 activity by AMPK in response to regu-
lar aerobic exercise contributes to decreased intramyocellular lipid ac-
cumulation and muscle plasticity, providing a molecular mechanism
that may represent an attractive target in metabolic syndromes.
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